Raymond James Financial Services Advisors, Inc. Uni Qure N.V. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Uni Qure N.V. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 11,916 shares of QURE stock, worth $167,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,916
Previous 10,286
15.85%
Holding current value
$167,419
Previous $46,000
26.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding QURE
# of Institutions
155Shares Held
40.8MCall Options Held
925KPut Options Held
617K-
Vestal Point Capital, LP New York, NY4.75MShares$66.7 Million1.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.78MShares$39.1 Million0.81% of portfolio
-
Boxer Capital, LLC San Diego, CA2.23MShares$31.3 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$30.8 Million0.01% of portfolio
-
Abrdn PLC1.93MShares$27.1 Million0.02% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $657M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...